Back to ELVN
Versant Capital Management, Inc → ELVN
Versant Capital Management, Inc ELVN Position History
Enliven Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$74K
Q3 2026
Peak value
$80K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $11K |
| Q4 2025 | $3K |
| Q1 2026 | $62K |
| Q2 2026 | $80K |
| Q3 2026 | $74K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $74K | 1.6K | — | — |
| Q2 2026 | $80K | 1.6K | — | — |
| Q1 2026 | $62K | 1.6K | — | — |
| Q4 2025 | $3K | 212 | — | — |
| Q3 2025 | $11K | 545 | — | — |
Other funds holding ELVN
$101.9M
$101.9M
$61.7M
$61.6M
$61.6M
$42.8M